BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Howard SAH, Krajewski KM, Jagannathan JP, Braschi-amirfarzan M, Tirumani SH, Shinagare AB, Ramaiya NH. A New Look at Toxicity in the Era of Precision Oncology: Imaging Findings, Their Relationship With Tumor Response, and Effect on Metastasectomy. American Journal of Roentgenology 2016;207:4-14. [DOI: 10.2214/ajr.15.15480] [Cited by in Crossref: 14] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Braschi-Amirfarzan M, Tirumani SH, Hodi FS Jr, Nishino M. Immune-Checkpoint Inhibitors in the Era of Precision Medicine: What Radiologists Should Know. Korean J Radiol 2017;18:42-53. [PMID: 28096717 DOI: 10.3348/kjr.2017.18.1.42] [Cited by in Crossref: 26] [Cited by in F6Publishing: 17] [Article Influence: 5.2] [Reference Citation Analysis]
2 Ruggeri RM, Campennì A, Giuffrida G, Trimboli P, Giovanella L, Trimarchi F, Cannavò S. Endocrine and metabolic adverse effects of immune checkpoint inhibitors: an overview (what endocrinologists should know). J Endocrinol Invest 2019;42:745-56. [PMID: 30471004 DOI: 10.1007/s40618-018-0984-z] [Cited by in Crossref: 26] [Cited by in F6Publishing: 16] [Article Influence: 6.5] [Reference Citation Analysis]
3 Thomas R, Sebastian B, George T, Majeed NF, Akinola T, Laferriere SL, Braschi-Amirfarzan M. A review of the imaging manifestations of immune check point inhibitor toxicities. Clin Imaging 2020;64:70-9. [PMID: 32334270 DOI: 10.1016/j.clinimag.2020.04.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Jadvar H. The Use of Imaging in the Prediction and Assessment of Cancer Treatment Toxicity. Diagnostics (Basel) 2017;7:E43. [PMID: 28726731 DOI: 10.3390/diagnostics7030043] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
5 Somarouthu B, Lee SI, Urban T, Sadow CA, Harris GJ, Kambadakone A. Immune-related tumour response assessment criteria: a comprehensive review. Br J Radiol 2018;91:20170457. [PMID: 29172675 DOI: 10.1259/bjr.20170457] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 7.5] [Reference Citation Analysis]